Abstract
Osteoclasts are terminally differentiated multinucleated giant cells that mediate bone resorption and regulate skeletal homeostasis under physiological and pathological states. Excessive osteoclast activity will give rise to enhanced bone resorption, being responsible for a wide range of metabolic skeletal diseases, ranging from osteoporosis and rheumatoid arthritis to tumor-induced osteolysis. Therefore, the construction of in vitro models of osteoclast-mediated bone resorption is helpful to better understand the functional status of osteoclasts under (patho)physiological conditions. Notably, it is essential to provide an in vivo-relevant bone substrate that induces osteoclasts to generate authentic resorption lacunae and excavate bone. Here, we summarize the experimental design of a reproducible and cost-effective method, which is suitable for evaluating the regulatory mechanisms and influence of molecular agonists and antagonists as well as therapeutics on osteoclast-mediated bone-resorbing activity. Key features • Experiments are performed using bovine cortical bone slices to simulate bone substrate resorption by murine osteoclasts in vivo. • The method allows for quantification of bone resorption in vitro. • The method is suitable for evaluating the regulatory mechanisms that control osteoclast-mediated bone-resorbing activity.
Keywords:
Bone resorption; Bone slices; Cell culture; Osteoclast; Resorption pits.